Loss of hepatic Lgr4 and Lgr5 promotes nonalcoholic fatty liver disease
Authors: Saponara Enrica , Penno Carlos , Matadamas Guzmán Meztli L. , Brun Virginie , Fischer Benoit , Brousseau Margaret , Wang Zhong-Yi , ODonnell Peter , Turner Jonathan , Meyer Alexandra Graff , Bollepalli Laura , d’Ario Giovanni , Roma Guglielmo , Carbone Walter , Orsini Vanessa , Annunziato Stefano , Obrecht Michael , Beckmann Nicolau , Saravanan Chandra , Osmont Arnaud , Tropberger Philipp , Richards Shola , Genoud Christel , Aebi Alexandra , Ley Svenja , Ksiazek Iwona , Nigsch Florian , Terraciano Luigi , Bouwmeester Tewis , Tchorz Jan , Ruffner Heinz 
Published: November 2021

Background & Aims

The Rspo-Lgr4/5-Znrf3/Rnf43 module is a master regulator of hepatic Wnt/β-catenin signaling and metabolic zonation, but its impact on nonalcoholic fatty liver disease (NAFLD) remains unclear. We studied whether liver-specific loss of the Wnt/β-catenin modulators Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 4/5 (Lgr4/5) promotes nonalcoholic fatty liver disease (NAFLD).

Methods

Mice with liver-specific deletion of both receptors Lgr4/5 (Lgr4/5dLKO) were fed with normal diet (ND) or high fat diet (HFD). Livers of these mice were analyzed for lipid and fibrotic content by tissue staining and immunohistochemistry (IHC), and lipoproteins, inflammation and liver enzyme markers were measured in blood. Mechanistic insights into hepatic lipid accumulation were obtained by using ex vivo primary hepatocyte cultures derived from the Lgr4/5dLKO mice. Lipid analysis of mouse livers was performed by mass spectrometry (MS)-based untargeted lipidomic analysis.

Results

We demonstrated that liver-specific ablation of Lgr4/5-mediated Wnt signaling resulted in hepatic steatosis, impaired bile acid (BA) secretion and predisposition to liver fibrosis. Under HFD conditions, we observed progressive intrahepatic fat accumulation, developing into macro-vesicular steatosis. Serum lipoprotein levels in HFD-fed Lgr4/5dLKO mice were decreased, rather than increased, suggesting that accumulation of fat in the liver was due to impaired lipid secretion by hepatocytes. Our lipidome analysis revealed a severe alteration of several lipid species in livers of Lgr4/5dLKO mice, including triacylglycerol estolides (TG-EST), a storage form of bioactive free fatty acid (FA) esters of hydroxy FAs (FAHFAs).

Conclusions

Loss of hepatic Wnt/β-catenin activity by Lgr4/5 deletion led to deregulation of lipoprotein pathways, loss of BA secretion, intrinsic alterations of lipid homeostasis and the onset of NAFLD.

Lay summary

The Wnt/β-catenin pathway plays an important role during development and tissue homeostasis. Loss of Wnt/β-catenin activity in mouse liver leads to loss of liver zonation, but the impact on nonalcoholic fatty liver disease (NAFLD) remains unclear. We show that livers of mice developed steatosis upon deletion of the positive pathway regulators Lgr4/5. Livers of knock-out (KO) mice exhibited altered lipid composition due to impaired lipid secretion. Furthermore, livers of these mice developed a nonalcoholic steatohepatitis (NASH)-like phenotype and fibrotic features derived from activated hepatic stellate cells. Our data demonstrate a protective role of Wnt/β-catenin pathway activity towards the development of NAFLD.

Highlights

Abrogation of hepatic Wnt/β-catenin activity and liver zonation upon Lgr4/5 deletion in mice led to hepatic steatosis.

Liver fat accumulation was caused by impaired lipid secretion from hepatocytes.

Steatotic livers contained increased levels of diverse lipid species, including polyunsaturated fatty acids and triglycerol-estolides.

These data confirmed that a decrease in Wnt/β-catenin signaling led to the development of nonalcoholic fatty liver disease (NAFLD) in mice.